TORONTO--(BUSINESS WIRE)--Greenbrook TMS Inc. (TSX:GTMS) (“Greenbrook” or the “Company”), a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy in the United States, is pleased to announce that it has entered into an agreement with Kaiser Foundation Health Plan of the Mid-Atlantic States, Inc. (“Kaiser”) pursuant to which Greenbrook and its affiliates will provide TMS therapy services to Kaiser members in Maryland, Virginia and the District of Columbia.
Kaiser selected Greenbrook based on its patient-focused customer service model, its clinical leadership and its ability to serve Kaiser’s geographically diverse member base. Pursuant to the agreement, Kaiser’s more than 765,000 members will initially have access to TMS therapy at 19 Greenbrook TMS Center locations located in Northern Virginia and Suburban Maryland.
“We applaud Kaiser on extending access to TMS therapy to its members and are pleased that Greenbrook was selected as Kaiser’s TMS therapy provider in the Mid-Atlantic States,” stated Bill Leonard, President and Chief Executive Officer of Greenbrook. Continued Leonard. “We are excited to provide Kaiser’s members and physicians with access to high-quality, customer centric TMS therapy services at Greenbrook’s TMS Center locations.”
About Greenbrook TMS Inc.
Operating through 68 Company-operated treatment centers, Greenbrook is a leading provider of TMS, an FDA-cleared, non-invasive therapy for the treatment of Major Depressive Disorder and other mental health disorders, in the United States. TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. Greenbrook has provided more than 220,000 TMS treatments to over 6,000 patients struggling with depression.
Certain information in this press release constitutes forward-looking information. In some cases, but not necessarily in all cases, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “targets”, “expects” or “does not expect”, “is expected”, “an opportunity exists”, “is positioned”, “estimates”, “intends”, “assumes”, “anticipates” or “does not anticipate” or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might”, “will” or “will be taken”, “occur” or “be achieved”. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances contain forward-looking information. Statements containing forward-looking information are not historical facts but instead represent management’s expectations, estimates and projections regarding future events.
Forward-looking information is necessarily based on a number of opinions, assumptions and estimates that, while considered reasonable by the Company as of the date of this press release, are subject to known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking information, including but not limited to the factors described in greater detail in the “Risk Factors” section of the Company’s annual information form dated March 27, 2019 which is available at www.sedar.com. These factors are not intended to represent a complete list of the factors that could affect the Company; however, these factors should be considered carefully. There can be no assurance that such estimates and assumptions will prove to be correct. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company expressly disclaims any obligation to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law.